| Vivo Bio Tech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 511509 |
NSE Symbol : - |
P/E(TTM) : 7.72 |
|
ISIN Demat : INE380K01017 |
Div & Yield% : - |
EPS(TTM) : 5.04 |
|
Book Value(₹) : 40.18 |
Market Cap(₹Cr) : 58.02 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 12.04 | 10.13 | 11.55 | 12.71 | 9.04 | 11.58 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 12.04 | 10.13 | 11.55 | 12.71 | 9.04 | 11.58 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.63 | 0.01 | 0.01 | 0.03 | 0.00 | 0.00 |
| Total Income | 16.67 | 10.15 | 11.56 | 12.74 | 9.04 | 11.58 |
| Total Expenditure | 6.36 | 5.76 | 6.22 | 6.33 | 4.27 | 6.98 |
| PBIDT | 10.30 | 4.39 | 5.34 | 6.41 | 4.78 | 4.60 |
| Interest | 2.06 | 1.92 | 1.52 | 2.22 | 2.09 | 1.95 |
| PBDT | 8.24 | 2.46 | 3.82 | 4.19 | 2.69 | 2.65 |
| Depreciation | 2.29 | 2.23 | 2.43 | 2.28 | 2.30 | 2.29 |
| Tax | 0.78 | 0.20 | 0.73 | 0.60 | 0.18 | 0.17 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.15 | -0.14 | -0.03 | -0.01 | -0.04 | -0.06 |
| Reported Profit After Tax | 5.31 | 0.18 | 0.70 | 1.32 | 0.25 | 0.26 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 5.31 | 0.18 | 0.70 | 1.32 | 0.25 | 0.26 |
| EPS (Unit Curr.) | 3.56 | 0.12 | 0.47 | 0.89 | 0.16 | 0.17 |
| EPS (Adj) (Unit Curr.) | 3.56 | 0.12 | 0.47 | 0.89 | 0.16 | 0.17 |
| Calculated EPS (Unit Curr.) | 3.56 | 0.12 | 0.47 | 0.89 | 0.16 | 0.17 |
| Calculated EPS (Adj) (Unit Curr.) | 3.56 | 0.12 | 0.47 | 0.89 | 0.16 | 0.17 |
| Calculated EPS (Ann.) (Unit Curr.) | 14.26 | 0.48 | 1.87 | 3.55 | 0.66 | 0.69 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 14.26 | 0.48 | 1.87 | 3.55 | 0.66 | 0.69 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 14.90 | 14.90 | 14.90 | 14.90 | 14.90 | 14.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 85.55 | 43.34 | 46.23 | 50.43 | 52.88 | 39.72 |
| PBDTM(%) | 68.44 | 24.28 | 33.07 | 32.97 | 29.76 | 22.88 |
| PATM(%) | 44.10 | 1.78 | 6.06 | 10.39 | 2.77 | 2.25 |